Meiling Yu

1.2k total citations
55 papers, 968 citations indexed

About

Meiling Yu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Meiling Yu has authored 55 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Pharmacology and 10 papers in Oncology. Recurrent topics in Meiling Yu's work include Connexins and lens biology (16 papers), Heat shock proteins research (8 papers) and Cancer-related molecular mechanisms research (5 papers). Meiling Yu is often cited by papers focused on Connexins and lens biology (16 papers), Heat shock proteins research (8 papers) and Cancer-related molecular mechanisms research (5 papers). Meiling Yu collaborates with scholars based in China, United States and South Korea. Meiling Yu's co-authors include Ben-Quan Qi, Xuhui Tong, Shuying Dong, Jian Xu, Xiaolin Liu, Guojun Jiang, Liang Tao, Cuiling Zhang, Dongdong Yuan and Binbin Yu and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Meiling Yu

50 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiling Yu China 19 559 161 124 119 98 55 968
Yiwei Li China 17 457 0.8× 139 0.9× 86 0.7× 114 1.0× 60 0.6× 35 1.1k
Zeyao Tang China 21 681 1.2× 209 1.3× 73 0.6× 192 1.6× 118 1.2× 56 1.3k
Ying Yin China 19 496 0.9× 68 0.4× 144 1.2× 80 0.7× 73 0.7× 45 1.1k
Simiao Qiao China 16 434 0.8× 102 0.6× 91 0.7× 83 0.7× 69 0.7× 32 865
Qiang Tang China 17 585 1.0× 229 1.4× 122 1.0× 195 1.6× 112 1.1× 44 1.1k
Jian Lv China 17 598 1.1× 174 1.1× 110 0.9× 253 2.1× 81 0.8× 38 950
Wan‐Jung Lu Taiwan 22 479 0.9× 88 0.5× 154 1.2× 104 0.9× 39 0.4× 54 1.2k
Yin Cai China 23 648 1.2× 214 1.3× 67 0.5× 118 1.0× 81 0.8× 84 1.4k
Jie-Jen Lee Taiwan 19 364 0.7× 135 0.8× 72 0.6× 180 1.5× 63 0.6× 34 1.1k

Countries citing papers authored by Meiling Yu

Since Specialization
Citations

This map shows the geographic impact of Meiling Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Yu more than expected).

Fields of papers citing papers by Meiling Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiling Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Yu. The network helps show where Meiling Yu may publish in the future.

Co-authorship network of co-authors of Meiling Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Meiling Yu. A scholar is included among the top collaborators of Meiling Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiling Yu. Meiling Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Jie, Shuxin Wang, Zhao Min, et al.. (2025). FGF4-FGFR1 signaling promotes podocyte survival and glomerular function to ameliorate diabetic kidney disease in male mice. Nature Communications. 16(1). 10430–10430.
3.
Wu, Honglong, et al.. (2025). STAT3 mediates CAF-induced osimertinib resistance via regulating protein secretion in non-small cell lung cancer. Frontiers in Pharmacology. 16. 1546491–1546491.
4.
5.
Liu, Mingda, et al.. (2024). Correlations of the expression of Cx43, SCFFBXW7, p-cyclin E1 (Ser73), p-cyclin E1 (Thr77) and p-cyclin E1 (Thr395) in colon cancer tissues. World Journal of Gastrointestinal Oncology. 17(1). 98410–98410.
6.
Yu, Meiling, Sheng Wu, Ben-Quan Qi, Xiaofei Wu, & Ximing Deng. (2023). Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection. Biomedical Reports. 19(2). 51–51. 2 indexed citations
7.
Yu, Meiling, et al.. (2023). Baicalein ameliorates polymyxin B-induced acute renal injury by inhibiting ferroptosis via regulation of SIRT1/p53 acetylation. Chemico-Biological Interactions. 382. 110607–110607. 30 indexed citations
8.
Yu, Meiling, Xiaoxue Tian, Shiyu Chen, et al.. (2021). Downregulation of Cx43 reduces cisplatin-induced acute renal injury by inhibiting ferroptosis. Food and Chemical Toxicology. 158. 112672–112672. 25 indexed citations
9.
Ding, Feng, et al.. (2018). Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations. Drug Design Development and Therapy. Volume 12. 757–767. 14 indexed citations
10.
Yu, Meiling, et al.. (2017). Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. Biomedicine & Pharmacotherapy. 90. 677–685. 185 indexed citations
11.
Yu, Meiling, et al.. (2016). Severe adverse reactions caused by omeprazole: A case report. Experimental and Therapeutic Medicine. 12(2). 1103–1106. 12 indexed citations
12.
Kong, Lingti, et al.. (2016). The Effect of Vinpocetine on Human Cytochrome P450 Isoenzymes by Using a Cocktail Method. Evidence-based Complementary and Alternative Medicine. 2016(1). 5017135–5017135. 3 indexed citations
13.
Jiang, Guojun, Shuying Dong, Meiling Yu, et al.. (2016). Influence of gap junction intercellular communication composed of connexin 43 on the antineoplastic effect of adriamycin in breast cancer cells. Oncology Letters. 13(2). 857–866. 17 indexed citations
14.
Liu, Hongtao, et al.. (2015). Proton pump inhibitor-induced exfoliative dermatitis: A case report. Experimental and Therapeutic Medicine. 11(2). 543–546. 4 indexed citations
15.
Wang, Lingzhi, et al.. (2015). Simvastatin protects Sertoli cells against cisplatin cytotoxicity through enhanced gap junction intercellular communication. Oncology Reports. 34(4). 2133–2141. 10 indexed citations
16.
Tong, Xuhui, Xi Han, Binbin Yu, et al.. (2014). Role of gap junction intercellular communication in testicular leydig cell apoptosis induced by oxaliplatin via the mitochondrial pathway. Oncology Reports. 33(1). 207–214. 13 indexed citations
17.
Yu, Meiling, et al.. (2014). Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT. Oncology Reports. 31(6). 2751–2758. 53 indexed citations
18.
Tong, Xuhui, Shuying Dong, Meiling Yu, Qin Wang, & Liang Tao. (2013). Role of heteromeric gap junctions in the cytotoxicity of cisplatin. Toxicology. 310. 53–60. 18 indexed citations
19.
Zhang, Cuiling, Xuhui Tong, Ben-Quan Qi, et al.. (2013). Components of Panax notoginseng saponins enhance the cytotoxicity of cisplatin via their effects on gap junctions. Molecular Medicine Reports. 8(3). 897–902. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiwei Li Breakdown of academic impact, for papers by Zeyao Tang Breakdown of academic impact, for papers by Ying Yin Breakdown of academic impact, for papers by Simiao Qiao Breakdown of academic impact, for papers by Qiang Tang Breakdown of academic impact, for papers by Jian Lv Breakdown of academic impact, for papers by Wan‐Jung Lu Breakdown of academic impact, for papers by Yin Cai Breakdown of academic impact, for papers by Jie-Jen Lee
Rankless by CCL
2026